Schrauwen P, van Baak M A
Department of Human Biology, University of Limburg, Maastricht, The Netherlands.
Int J Sports Med. 1995 Oct;16(7):439-44. doi: 10.1055/s-2007-973034.
beta-Adrenoceptor blocking agents impair endurance exercise performance in healthy subjects and in patients with hypertension. A possible explanation for the reduced exercise tolerance is a diminished availability of plasma non-esterified fatty acids (NEFA) for energy production during exercise. This study investigated the effect of beta-adrenoceptor blockade on NEFA uptake of exercising skeletal muscle at elevated blood NEFA concentrations. In 11 healthy volunteers a triacylglycerol emulsion was infused at increasing rate for 1 hour before and 1 hour during one-armed cranking exercise at 60% Wpeak with and without prior administration of the beta 1+2-adrenoceptor blocking agent propranolol (80 mg per os). Arteriovenous concentration differences of NEFA across the active forearm were measured and forearm blood flow was estimated using venous occlusion plethysmography. Heart rate and blood flow were significantly lower after propranolol (p < 0.05). Propranolol did not affect arterial NEFA concentration, arteriovenous NEFA difference or NEFA flux significantly. Net NEFA uptake increased with increasing arterial NEFA concentration or inflow in a similar manner with and without prior propranolol administration. Therefore, the results do not support the hypothesis that beta-adrenergic activity plays a role in the regulation of active skeletal muscle NEFA uptake under the conditions studied.
β-肾上腺素受体阻滞剂会损害健康受试者和高血压患者的耐力运动表现。运动耐力降低的一个可能解释是运动期间用于能量产生的血浆非酯化脂肪酸(NEFA)可用性降低。本研究调查了在血液NEFA浓度升高时β-肾上腺素受体阻断对运动骨骼肌NEFA摄取的影响。在11名健康志愿者中,在单臂曲柄运动(以60%Wpeak强度)期间及之前1小时,以递增速率输注三酰甘油乳剂1小时,运动时分为给予和未给予β1+2-肾上腺素受体阻滞剂普萘洛尔(80mg口服)两种情况。测量了主动前臂的NEFA动静脉浓度差,并使用静脉阻塞体积描记法估算前臂血流量。服用普萘洛尔后心率和血流量显著降低(p<0.05)。普萘洛尔对动脉NEFA浓度、NEFA动静脉差值或NEFA通量没有显著影响。无论是否预先给予普萘洛尔,净NEFA摄取均以相似方式随动脉NEFA浓度或流入量增加而增加。因此,研究结果不支持β-肾上腺素能活性在所研究条件下对活跃骨骼肌NEFA摄取调节起作用这一假说。